ALL (Acute Lymphoblastic Leukemia) studies

ALL (Acute Lymphoblastic Leukemia) studies examine how the disease develops, how it can be detected early, and how effective different treatments are. Researchers look at genetic factors, response to chemotherapy, and new targeted therapies to improve outcomes. They also explore ways to reduce side effects, prevent relapse, and personalize treatment plans. These studies aim to better understand the biology of ALL, identify risk factors, and find more effective, less toxic options for patients of all ages. Overall, they contribute to advancing knowledge and improving survival rates for those affected by this blood cancer.